Full-time employees: 16
|Mr. Ahmad Ali Mortazavi||Exec. Chairman||N/A||N/A||1971|
|Ms. Sarah Clare||Director of Fin. & Compliance||N/A||N/A||N/A|
|Mr. Jonny Wray||Chief Technology Officer||N/A||N/A||N/A|
|Mr. Alan Whitmore||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Colin Stubberfield||Chief Research Officer||N/A||N/A||N/A|
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
e-Therapeutics plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS)
. Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.